Private Capital Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Hold
20
﹤0.01% 1711
2022
Q1
$1K Hold
20
﹤0.01% 1941
2021
Q4
$1K Buy
20
+15
+300% +$560 ﹤0.01% 1938
2021
Q3
$0 Sell
5
-26
-84% -$1.09K ﹤0.01% 2171
2021
Q2
$1K Buy
+31
New +$1.37K ﹤0.01% 1967
2020
Q2
Sell
-36
Closed -$1K 2053
2020
Q1
$1K Hold
36
﹤0.01% 1800
2019
Q4
$0 Hold
36
﹤0.01% 2062
2019
Q3
$1K Buy
+36
New +$593 ﹤0.01% 2032
2019
Q2
Sell
-36
Closed -$1K 2298
2019
Q1
$1K Hold
36
﹤0.01% 2033
2018
Q4
$1K Buy
+36
New +$574 ﹤0.01% 2037

Other funds holding HALO

Private Capital Group's HALO Position: Q2 2022 in Review

Private Capital Group held its Halozyme (HALO) position steady in Q2 2022 at 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Private Capital Group first reported a position in HALO in Q4 2018 and has held it in 10 quarters since. 368 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Private Capital Group held 20 shares of Halozyme worth $1K as of Q2 2022.
  • Private Capital Group left its Halozyme share count unchanged in Q2 2022.
  • Halozyme made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1711 holding.
  • Private Capital Group first reported a position in Halozyme in Q4 2018 and has held it in 10 quarters since.
  • 368 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.